Skip to content

Study comparing the efficacy of intravenous oxytocin and intravenous carbetocin in haemodynamic stability of patients undergoing caesarean section under spinal anesthesia

A Randomised control trial comparing the efficacy of intravenous oxytocin and intravenous carbestocin in haemodynamic stability of patients undergoing caesarean section under spinal anesthesia

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044710
Enrollment
80
Registered
2022-08-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Intravenous oxytocin: Intravenous oxytocin 3 units bolus followed by 20 units in 500 ml normal saline at 100ml per hour Control Intervention1: Intravenous carbetocin: Intravenous carbet

Sponsors

Sabari C G S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age between 18 to 40 years. 2) American Society of Anaesthesiologists physical status II 3) Patients undergoing elective caesarean section under regional anaesthesia. 4) Provides Consent.

Exclusion criteria

Exclusion criteria: 1) Presence of hypertension, preeclampsia, cardiac, renal or liver diseases, epilepsy and patients undergoing general anaesthesia. 2) Patient who are unable or unwilling to give consent. � Women with history of hypersensitivity to carbetocin. � Patients who do not fulfil inclusion criteria.

Design outcomes

Primary

MeasureTime frame
to compare the haemodynamic effects of oxytocin and carbetocinTimepoint: 15 seconds before giving drug every 15 seconds for 5 minutes after giving drug

Secondary

MeasureTime frame
use of additional uterotonic agents haemoglobin level preoperatively andTimepoint: 2 hours and 24 hours postoperatively

Countries

India

Contacts

Public ContactDR SABARI C G S

Jawaharlal Nehru Medical College

drvinayakjannu84@gmail.com9743908033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026